These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35786135)

  • 21. Single-isomer levalbuterol: a review of the acute data.
    Nowak R
    Curr Allergy Asthma Rep; 2003 Mar; 3(2):172-8. PubMed ID: 12562558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma.
    Nelson HS; Bensch G; Pleskow WW; DiSantostefano R; DeGraw S; Reasner DS; Rollins TE; Rubin PD
    J Allergy Clin Immunol; 1998 Dec; 102(6 Pt 1):943-52. PubMed ID: 9847435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levalbuterol versus albuterol for acute asthma: a systematic review and meta-analysis.
    Jat KR; Khairwa A
    Pulm Pharmacol Ther; 2013 Apr; 26(2):239-48. PubMed ID: 23207739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease.
    Spencer M; Briggs AH; Grossman RF; Rance L
    Pharmacoeconomics; 2005; 23(6):619-37. PubMed ID: 15960557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levalbuterol nebulizer solution: is it worth five times the cost of albuterol?
    Asmus MJ; Hendeles L
    Pharmacotherapy; 2000 Feb; 20(2):123-9. PubMed ID: 10678290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of the LABA/LAMA dual bronchodilator indacaterol/glycopyrronium in a Swedish healthcare setting.
    Price D; Keininger D; Costa-Scharplatz M; Mezzi K; Dimova M; Asukai Y; Ställberg B
    Respir Med; 2014 Dec; 108(12):1786-93. PubMed ID: 25307414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects.
    Tripp K; McVicar WK; Nair P; Corren J; Pleskow WW; Goodwin E; Baumgartner RA; Hanrahan JP
    J Allergy Clin Immunol; 2008 Sep; 122(3):544-9. PubMed ID: 18692886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical experience with levalbuterol.
    Nelson HS
    J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 2):S77-84. PubMed ID: 10452792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pairwise comparison of levalbuterol versus racemic albuterol in the treatment of moderate-to-severe asthma.
    Pleskow WW; Nelson HS; Schaefer K; Claus R; Roach JM
    Allergy Asthma Proc; 2004; 25(6):429-36. PubMed ID: 15709454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the dose response to levalbuterol with and without pretreatment with S-albuterol after methacholine-induced bronchoconstriction.
    Raissy HH; Harkins M; Esparham A; Kelly HW
    Pharmacotherapy; 2007 Sep; 27(9):1231-6. PubMed ID: 17723076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-response evaluation of levalbuterol versus racemic albuterol in patients with asthma.
    Handley DA; Tinkelman D; Noonan M; Rollins TE; Snider ME; Caron J
    J Asthma; 2000 Jun; 37(4):319-27. PubMed ID: 10883742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A UK-based cost-utility analysis of indacaterol, a once-daily maintenance bronchodilator for patients with COPD, using real world evidence on resource use.
    Price D; Asukai Y; Ananthapavan J; Malcolm B; Radwan A; Keyzor I
    Appl Health Econ Health Policy; 2013 Jun; 11(3):259-74. PubMed ID: 23529714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Addition of levalbuterol to a pediatric emergency department automated medication management system does not increase its use.
    Conners GP; Hays DP; Richardson T; Zwemer FL
    Int J Emerg Med; 2009 Dec; 2(4):251-4. PubMed ID: 20436896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levalbuterol versus racemic albuterol in the treatment of acute exacerbation of asthma in children.
    Hardasmalani MD; DeBari V; Bithoney WG; Gold N
    Pediatr Emerg Care; 2005 Jul; 21(7):415-9. PubMed ID: 16027572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A patient satisfaction survey comparing levalbuterol with racemic albuterol in children.
    Berger WE; Ames DE; Harrison D
    Allergy Asthma Proc; 2004; 25(6):437-44. PubMed ID: 15709455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrospective comparison of nebulized levalbuterol and albuterol for adverse events in patients with acute airflow obstruction.
    Scott VL; Frazee LA
    Am J Ther; 2003; 10(5):341-7. PubMed ID: 12975718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Case report: Paradoxical responses to short acting beta-agonists in a pediatric patient.
    Graden A; Gandhi S; Joshi AY
    J Asthma; 2021 Feb; 58(2):213-215. PubMed ID: 31573361
    [No Abstract]   [Full Text] [Related]  

  • 38. A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults.
    Nowak R; Emerman C; Hanrahan JP; Parsey MV; Hanania NA; Claus R; Schaefer K; Baumgartner RA;
    Am J Emerg Med; 2006 May; 24(3):259-67. PubMed ID: 16635694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levalbuterol for asthma: a better treatment?
    Kelly HW
    Curr Allergy Asthma Rep; 2007 Jul; 7(4):310-4. PubMed ID: 17547854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of acute bronchospasm in elderly patients.
    Berger WE
    Postgrad Med; 2005 Dec; 118(6 Suppl Acute):34-7; discussion 38. PubMed ID: 19667714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.